Breeze Meds vs Gala: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

49 providers verified independently·Independent researchHow we rank →

Breeze Meds beats Gala overall, scoring 7.3/10 vs 7.2/10. Gala is more affordable at $149/mo vs $199/mo. Choose Breeze Meds for users who want a straightforward compounded glp-1 program wi. Choose Gala for tirzepatide-first patients who want a low-cost compounded pa.

A side-by-side comparison of Breeze Meds and Gala covering pricing, scores, medication types, insurance, and more to help you decide.

Higher Rated

Breeze Meds

#34 of 49
7.3/10

Compounded GLP-1 provider focused on fast shipping and a no-fuss enrollment process.

Visit Breeze Meds

Gala

#40 of 49
7.2/10

Telehealth platform focused on compounded tirzepatide — both microdose and full-dose tiers — alongside a brand-name semaglutide (Ozempic) path and a 'coming soon' Wegovy pill. Operated by AI Coaching, Inc. (Wilmington, DE), backed by OpenLoop-affiliated medical groups (a recognized US telehealth backend) and LegitScript verified. Differentiator: a dedicated 'Gala GLP-1 Tracker' iOS + Android app for in-treatment dosing, weight, and side-effect logging.

Visit Gala
FeatureBreeze MedsGala
Our Score7.3/107.2/10
Starting Price$199/mo$149/mo
Medication TypeCompoundedBoth
Insurance AcceptedNoNo
Best ForUsers who want a straightforward compounded GLP-1 program with fast shippingTirzepatide-first patients who want a low-cost compounded path (microdose $149/mo or full-dose $179-199/mo) plus a dedicated iOS + Android tracker app for daily progress logging
Ranking#34#40

Pros & Cons Compared

Breeze Meds

Pros

  • +No subscription required — order on demand without recurring billing commitments
  • +Three formulation options: injectable semaglutide, oral semaglutide tablet, and oral tirzepatide tablet
  • +FSA/HSA eligible for those with health savings accounts
  • +Discreet packaging on all shipments

Cons

  • Very limited independent reviews and unclear company structure — legitimacy is hard to verify
  • Oral options at $299-399/mo are significantly more expensive than injectable alternatives
  • Not available in all 50 states — varies by provider licensure in your state

Gala

Pros

  • +Microdose compounded tirzepatide at $149/mo — the cheapest microdose tirz on a tracked telehealth platform; full-dose compounded tirzepatide at $179/mo (yearly plan) or $199/mo (3-month plan)
  • +Dedicated 'Gala GLP-1 Tracker' on BOTH iOS and Android — first-party in-treatment logging is uncommon among compounded-only platforms
  • +OpenLoop-affiliated medical groups + LegitScript verification provide third-party accountability that many compounded-only platforms lack
  • +All 50 states, free shipping, no insurance required, 24/7 patient support claimed

Cons

  • Brand-name Ozempic pricing ($1,299/mo) is materially above market — NovoCare direct pricing for Wegovy is $349/mo, Hers offers Wegovy at $149/mo via the 2026 Novo Nordisk partnership
  • Tirzepatide-only on the compounded side — compounded semaglutide is NOT offered, narrower medication menu than peers like Maximus, Ro, or Henry Meds
  • Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness — verify your specific dose and batch with each refill
  • Initial consultation typically a sync video visit, but ongoing follow-ups and questions are chat-based (no scheduled ongoing video access) — and no published labs, no named medical director, no specialty obesity oversight
  • Restrictive refund policy — Gala's published terms state 'IN NO EVENT SHALL YOU BE ISSUED A REFUND UPON CANCELLATION OF THE SUBSCRIPTION SERVICES' with a narrow exception for provider-initiated medical disqualification. No money-back guarantee. Read the published policy at galaglp1.com/refund-policy before enrolling on a commitment plan
  • Newer brand under AI Coaching, Inc. (founded 2024 per LinkedIn) — limited public company history; founders, founding year, and named medical director not publicly disclosed on galaglp1.com itself

Our Verdict

Breeze Meds edges out Gala with a score of 7.3/10 vs 7.2/10. If budget is your priority, Gala starts at $149/mo compared to Breeze Meds's $199/mo. Gala offers both brand-name and compounded medications, giving you more flexibility. Choose Breeze Meds if you want: users who want a straightforward compounded glp-1 program with fast shipping. Choose Gala if you want: tirzepatide-first patients who want a low-cost compounded path (microdose $149/mo or full-dose $179-199/mo) plus a dedicated ios + android tracker app for daily progress logging.

Still undecided? Editor's #1 Overall Pick

Embody

$299/mo · 7.3/10 · Compounded

If neither Breeze Meds nor Gala feels like the right fit, our overall #1 pick across all 49 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.

Try Breeze Meds

Starting at $199/mo

Visit Breeze Meds

Try Gala

Starting at $149/mo

Visit Gala

Related comparisons

Other matchups readers comparing Breeze Meds or Gala tend to look at next.

Top Picks

Four programs our readers click through most.

Embody

7.3/10
$299/mo·Compounded

Gala

7.2/10
$149/mo·Brand & Compounded

Sesame Care

7.9/10
$99/mo·Brand & Compounded

Affiliate links — we earn a commission at no extra cost to you. Selection reflects what readers convert through, not editorial endorsement. Full ranking + methodology at glp1picks.com.